Independent variable | β | S.E. | P | OR | 95% CI |
---|---|---|---|---|---|
Model 1 | Â | Â | Â | Â | Â |
Gender (women) | –1.211 | 0.339 | < 0.001 | 0.298 | 0.153-0.579 |
Age | 0.055 | 0.016 | 0.001 | 1.057 | 1.023-1.092 |
Lipid-lowering therapy | 1.223 | 0.401 | 0.002 | 3.396 | 1.548-7.452 |
1,5-AG | –0.044 | 0.017 | 0.008 | 0.957 | 0.927-0.989 |
Model 2 | Â | Â | Â | Â | Â |
Gender (women) | –1.101 | 0.334 | 0.001 | 0.332 | 0.173-0.640 |
Age | 0.056 | 0.017 | 0.001 | 1.058 | 1.024-1.092 |
Lipid-lowering therapy | 1.246 | 0.401 | 0.002 | 3.476 | 1.584-7.627 |
GA | 0.134 | 0.044 | 0.002 | 1.143 | 1.048-1.247 |